Home » Newsletters » BioWorld

BioWorld

July 2, 1998

View Archived Issues

Clarification

Complete Review Letter Issued For Centocor's Crohn's Drug

Gene Logic Signs Two Deals; Shares Soar 45 Percent

Pokeweed Toxin, Like Ricin, Zaps Bone Cancer In Mice

Other News To Note

Gilead To File For FDA Approval Of Preveon By Year's End

Holiday Notice

New AIDS Strategies Target Latent Cells, Immune Recovery

Aviron Seeks FDA Approval For Inhaled Flu Vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...